Inside Project
  • Home|
  • Inside Project Scalpel: The Autopsy of Trust

Inside Project Scalpel: The Autopsy of Trust

Inside Project Scalpel: The Autopsy of Trust

Inside Project Scalpel: The Autopsy of Trust
“Everything seems to be running fine. But something’s off. I can feel it — and I need someone who can smell what numbers can’t tell.”

That was the first thing the investor said to me — one of India’s top news-based healthcare backers, who had put capital and confidence into a growing hospital chain.

The books showed revenue. The graphs showed growth. But instinct whispered otherwise.

I was called in with one mandate: dissect everything without alarming the subject. We called it Project Scalpel.

What we found

In the first 10 days, we knew the rot wasn’t surface-level.

  • ₹8.4 crore had been given as vendor advances — over ₹6.9 crore of it was never adjusted, lying dormant for nearly a year.
  • Receivables showed patients who were long gone — even deceased — with bills still unpaid.
  • 50% of patient entries had no Medical Record Number. Some had duplicates. Some never existed.
  • IPD cash collection didn’t match the ledger — not even for the top 5 transactions we sampled.

We had only scratched the surface.

Layers beneath the Ledger

The deeper we went, the weirder it got.

  • Vendor master data showed names erased — but purchases had happened. Over ₹11 crore worth.
  • One charitable foundation, closely related to the board member’s family, had ₹94 lakhs stuck in advance for camps — but had paid zero yet.
  • A shell company with 29% shareholding had received ₹5.8 crore in funds — even though the majority owners had only paid ₹80 lakhs combined.
  • Journals were backdated. Entries were recorded on Sundays. Suspense accounts bulged.
  • And someone — maybe multiple people — were cycling funds between personal and official accounts.

Then came the people

Through discreet network probes, we started mapping assets, shadow entities, and off-books lifestyles.

  • Real estate in multiple cities, owned via individuals with no formal link to the company.
  • A loss-making pharma vendor selling to the hospital at inflated prices, traced back to a related party.
  • Advance consultancy fees being paid — twice — to the same insider, with hush entries split across branches.

The trail was muddy. But the pattern was clear: a deliberate decentralization of deceit.

How we solved it

  • Built a discreet digital twin of the business.
  • Conducted shadow audits of OPD, IPD, pharmacy, and financial entries.
  • Cross-mapped KMP payments, backdoor entries, and real estate trails.
  • Created a risk-scoring matrix for every transaction.
  • Froze the anomalies into a clean summary, backed by quantified impact: ₹30+ crore in financial exposure and material risk.
“You’ve helped me see my investment naked,” said the investor in the final meeting.
“Now I know where to suture — and where to amputate.”

That’s what we do. Not just investigate the crime, but decode the environment where it breeds.

— The author is Founder & MD at Intelaw Consulting. He can be reached at ravi@intelaw.org.